Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
about
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisTargeting Hepatocellular Carcinoma: What did we Discover so Far?Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant casePrognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis.Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma.Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis.Proton beam therapy for hepatocellular carcinoma.External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database.Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation.Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment.Management of liver cancer. The Surgeon's point of view.Evaluation of Novel 64Cu-Labeled Theranostic Gadolinium-Based Nanoprobes in HepG2 Tumor-Bearing Nude Mice.The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy.Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling.Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial.Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
P2860
Q26738533-E3EF42A4-7095-43BE-ACC0-AF2CC1706753Q28077283-CB76C005-CC9D-4FE1-9702-CC79A52B13DFQ30381174-18994907-F1D1-4D59-AC09-42577E7FF0EEQ33590673-2C1DEFE5-6730-4E58-8027-45F92DDD14F7Q35811557-EEF2F16B-C853-4A20-9F9D-8206CE02620FQ37124697-64113ED2-2A41-4622-B31E-072F36A85AB6Q37709160-42505343-C576-467D-9DAE-3865990A71CEQ37735607-A917AA22-CFA4-4C2C-9B22-83A444262D80Q37742983-E0575791-E454-4E48-8CDE-3E5302590BEAQ37744386-9F3EFB90-35FF-47FD-932A-58EBE4C34A59Q38616345-D0ACC2A6-F6FA-46A2-A814-A5740BD13ABEQ38688473-5B1AAFBF-6ACC-457C-8B98-01F105D7A609Q38719022-EAA6AED8-D2E2-4F47-A659-EE0DF7C6AF47Q38779808-EDAA4240-EDBE-4826-AC8D-7B6D5280D866Q38789667-D13526B0-2382-4317-B97F-D08D99BDD0EFQ38819393-F534ACC4-86DD-4BE1-A908-2BC620A61739Q39296812-506D7F65-D787-42B2-933A-0D25960F87F7Q41619308-2ABE8FFA-7017-457A-A0FC-BF29727A5AA7Q44634188-5C947595-A4DC-4078-B24A-44C0E6E655CAQ47150769-586BEEAE-E7D0-4F07-B88E-5108FCB9EAF9Q49300596-5ECEF256-A9D3-42EB-85D0-18B83B244AFFQ51494045-F2885E2A-3552-49AC-ADAD-0B412A64CDB4Q54974781-99802B09-3D2A-4D19-AB0D-ECD147D9D52AQ57174329-73918CD4-23BB-4340-B1EF-C32FE287450E
P2860
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@ast
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@en
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@nl
type
label
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@ast
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@en
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@nl
prefLabel
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@ast
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@en
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@nl
P2093
P2860
P356
P1476
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review.
@en
P2093
Anna Zygogianni
George Kyrgias
John Kouvaris
Maria-Aggeliki Kalogeridi
Sofia Chatziioannou
P2860
P304
P356
10.4254/WJH.V7.I1.101
P577
2015-01-01T00:00:00Z